HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Examination of lymphokines in patients with hemodialysis (author's transl)].

Abstract
The activity of LIF after Con A stimulation was examined in patients with hemodialysis and chronic uremia. It was found that LIF activity is reduced in uremia compared with healthy controls. The absolute number of T lymphocytes was reduced as well as the number of active E rosettes. An inhibitory effect was found in vitro by isolated middle molecules from uremic serum and ultrafiltrate. The LIF production of normal lymphocytes and the number of active rosettes are significantly reduced by substances isolated from serum and ultrafiltrate with molecular weight of 1 000 to 1 500 Dalton. The authors think that these uremic middle molecules are responsible for the already known reducing of immune response by uremia. The uremic substances are dialysable.
AuthorsL Löcsey, K Kálmán, M Hauck, G Kakuk
JournalAllergie und Immunologie (Allerg Immunol (Leipz)) Vol. 25 Issue 3 Pg. 211-7 ( 1979) ISSN: 0323-4398 [Print] Germany
Vernacular TitleUntersuchung der Lymphokin-Produktion bei hämodialysierten Patienten.
PMID162030 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Leukocyte Migration-Inhibitory Factors
  • Lymphokines
  • Toxins, Biological
  • Concanavalin A
Topics
  • Adult
  • Chronic Disease
  • Concanavalin A (pharmacology)
  • Female
  • Humans
  • Leukocyte Migration-Inhibitory Factors (biosynthesis)
  • Lymphokines (biosynthesis)
  • Male
  • Renal Dialysis
  • Toxins, Biological (blood)
  • Uremia (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: